Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Khan (Basel, Switzerland), A. Gazdhar (Bern, Switzerland), K. Fytianos (Bern, Switzerland), L. Fang (Basel, Switzerland), F. Caldana (Bern, Switzerland), M. Roth (Basel, Switzerland), M. Tamm (Basel, Switzerland), T. Geiser (Bern, Switzerland), K. Hostettler (Basel, Switzerland). The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo. 594

Member's Comments

No comment yet.

Related content which might interest you: Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Mesenchymal cells, immune cells and the lung stem cell niche Source: Eur Respir Monogr 2021; 91: 134-143 Year: 2021 Characterisation and hepatocyte-like differentiation of mesenchymal stem cells derived from adipose tissue of immunodeficient mice Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Immunophenotypic and functional characterization of adult lung epithelial and stromal progenitor cell targets Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008 Identification of MSC-like cells in human lung parenchyma capable of differentiating into airway epithelial cells Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair Source: ERS Lung Science Conference 2020 Year: 2020 Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Efficient gene transduction of adipose tissue-derived mesenchymal stem cells (MSCs) for asthma research Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011